Bumper Offer - Urjas oil Just @ Rs. 1 X
Jubira 5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of High Cholesterol. The alternative uses of Jubira 5 Tablet have also been explained below.
The correct dosage of Jubira 5 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Jubira 5 Tablet as well, which are listed below. These side effects of Jubira 5 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Jubira 5 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. Warnings related to Jubira 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Jubira 5 Tablet is contraindicated in people with pre-existing medical conditions like Kidney Disease, Hypothyroidism, Drug Allergy as it can result in adverse effects. The section on Jubira 5 Tablet contraindications lists all such conditions.
Drug reaction of Jubira 5 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Jubira 5 Tablet is considered safe while driving, and is addictive.
Jubira 5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Jubira 5 Tablet is used -
Severe
Moderate
Mild
Is the use of Jubira 5 Tablet safe for pregnant women?
Jubira should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Jubira 5 Tablet safe during breastfeeding?
Jubira may have very limited harmful effects for breastfeeding women.
What is the effect of Jubira 5 Tablet on the Kidneys?
Kidney can be affected by Jubira. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Jubira 5 Tablet on the Liver?
Jubira may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Jubira 5 Tablet on the Heart?
Jubira has very mild side effects on the heart.
Jubira 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Jubira 5 Tablet unless your doctor advises you to do so -
Is this Jubira 5 Tablet habit forming or addictive?
Forming a habit of Jubira 5 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Jubira 5 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Jubira 5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Jubira 5 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Jubira 5 Tablet
Taking Jubira 5 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Jubira 5 Tablet
Consumption of alcohol and Jubira 5 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650